SCHEMBL14835009

SCHEMBL14835009

BrCCCc1cnccn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
CYP2D6 P10635 2/20 0.32
VNN1 O95497 1/20 0.31
CYP1B1 Q16678 1/20 0.31
DAO P14920 1/20 0.30
TLR7 Q9NYK1 1/20 0.30
KDM4E B2RXH2 1/20 0.30
NAPRT Q6XQN6 1/20 0.30
HCAR2 Q8TDS4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5159759 0.94 HDAC3 (0.36) HSP90AA1CYP1A2CYP3A4HDAC3HDAC1
SCHEMBL31036036 0.92 HRH1 (0.35) HSP90AA1CYP1A2CYP3A4HDAC3HDAC1
SCHEMBL29263707 0.92 HRH1 (0.35) HSP90AA1CYP1A2CYP3A4HDAC3HDAC1
SCHEMBL1427937 0.86
SCHEMBL28362525 0.86 HSP90AA1 (0.40) HSP90AA1CYP1A2CYP3A4HDAC3HDAC1
SCHEMBL9741925 0.82 HDAC3 (0.31) HDAC3HDAC1HDAC2HDAC6HRH1
SCHEMBL6685246 0.78 POLB (0.40) HSP90AA1CYP1A2CYP3A4HDAC3HDAC1
SCHEMBL7718583 0.78 HSP90AA1 (0.34) HSP90AA1CYP1A2CYP3A4HDAC3HDAC1
SCHEMBL12441745 0.78 HSP90AA1 (0.34) HSP90AA1CYP1A2CYP3A4HDAC3HDAC1
SCHEMBL6287667 0.78 CYP2A6 (0.47) HSP90AA1HDAC3HDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576510-A1 PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER Amgen Inc. (US) 2013-04-10 EP disclosed
WO-2011153509-A1 PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER AMGEN INC. (US) 2011-12-08 WO disclosed